INSM
Insmed Inc Health Care Pharmaceutical Preparations Russell 3000
$112.58Close
$24.1BMarket cap
$91.88 – $211.4152-week range
Late-januaryNext report · estimated
Highlights
Cautions
- Not in an uptrend 0 of 8 trend conditions
- Lagging the market RS 27 · weaker than 73% of stocks over 12 months
- Far from its high 47% below its 52-week high
Price
Filing Results Screen pick 52-week high and low Adjusted prices
Key figures
Off 12-month high
47%
1wk
up 20.5%
price change
1mo
down 1.4%
price change
12-month return
down 42%
market up 11% ·
its own down 43%
F-score
5 / 9
Mixed
Altman Z
5.16
Low risk
P/E
—
price / earnings
PEG
—
P/E / EPS growth
P/B
32.6×
price / book
Earnings yield
down 5.2%
EBIT / enterprise value
Cheaper than
10%
of the market · expensive
Revenue growth
up 67%
year on year
EPS growth
—
latest quarter
Sales growth
up 268%
latest quarter · -28 pts
ROE
down 249%
return on equity
Free cash margin
down 160%
-$967.6M FCF
D/E
0.73
long-term debt / equity
Net debt / EBITDA
—
Interest cover
Lossoperating loss
Piotroski tests
- not yet profitable on its assets
- operating cash flow is negative
- short-term liquidity weakened
- issued more shares
- profitability improving
- profits backed by cash
- reduced long-term debt
- gross margin widened
- assets working harder
Repair signals
- Long-term debt down 51% ($1.1B → $0.5B)
- Gross margin 76.4% → 79.7%
Trade setup
ATR%
4.2%
$4.70 a day · 2×ATR $103.17
RS
27 / 99
vs the universe
Trend
0 / 8
trend template
Relative volume
1.9×
vs 50-day average
Up/down volume
0.95
50 sessions
Implied move
—
no scheduled report
Trend template · 0 of 8
Screen verdict
Did not qualify for any screen.
Warning signs
- Losing money before interest is even paid The company made an operating loss, so interest is not covered at all - the debt is being serviced from cash reserves, asset sales or new borrowing rather than from the business.
- Shareholders diluted The share count rose 19.4% over the year, from 179m to 214m shares. Each existing share owns a smaller fraction of the company than it did a year ago.
Last reported
Oct 29, 2026
Results reaction
Oct 29, 2026+18% vs market2 sessions after results
Financials
- Gross 80%
- Net -211%
- Free cash -160%
- Cash
- Long-term debt
| FY2020Dec 31, 2020 | FY2021Dec 31, 2021 | FY2022Dec 31, 2022 | FY2023Dec 31, 2023 | FY2024Dec 31, 2024 | FY2025Dec 31, 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $164.4M | $188.5M | $245.4M | $305.2M | $363.7M | $606.4M |
| Gross margin | 76% | 77% | 78% | 79% | 76% | 80% |
| Operating income | -$265.2M | -$375.1M | -$457.3M | -$709.6M | -$878.3M | -$1.2B |
| Net income | -$294.1M | -$434.7M | -$481.5M | -$749.6M | -$913.8M | -$1.3B |
| Net margin | -179% | -231% | -196% | -246% | -251% | -211% |
| Earnings per share | -$3.01 | -$3.88 | -$3.91 | -$5.34 | -$5.57 | -$6.42 |
| Free cash flow | -$225.6M | -$370.6M | -$410.3M | -$549.5M | -$705.8M | -$967.6M |
| Free cash margin | -137% | -197% | -167% | -180% | -194% | -160% |
| Cash | $532.8M | $716.8M | $1.1B | $482.4M | $555.0M | $510.4M |
| Long-term debt | $356.3M | $566.6M | $1.1B | $1.2B | $1.1B | $541.0M |
| Shareholders' equity | $275.9M | $410.5M | $88.0M | -$331.9M | $285.4M | $739.0M |
| Shares outstanding | 102.76m | 118.74m | 135.65m | 147.98m | 179.38m | 214.26m |
Filings
| Filed | Report | Period to | Lag |
|---|---|---|---|
| Oct 29, 2026 | Quarterly ↗ | Sep 30, 2026 | 29d |
| Aug 6, 2026 | Quarterly ↗ | Jun 30, 2026 | 37d |
| May 7, 2026 | Quarterly ↗ | Mar 31, 2026 | 37d |
| Feb 19, 2026 | Annual ↗ | Dec 31, 2025 | 50d |
| Oct 30, 2025 | Quarterly ↗ | Sep 30, 2025 | 30d |
| Aug 7, 2025 | Quarterly ↗ | Jun 30, 2025 | 38d |
| May 8, 2025 | Quarterly ↗ | Mar 31, 2025 | 38d |
| Feb 20, 2025 | Annual ↗ | Dec 31, 2024 | 51d |
| Oct 31, 2024 | Quarterly ↗ | Sep 30, 2024 | 31d |
| Aug 8, 2024 | Quarterly ↗ | Jun 30, 2024 | 39d |
| May 9, 2024 | Quarterly ↗ | Mar 31, 2024 | 39d |
| Feb 22, 2024 | Annual ↗ | Dec 31, 2023 | 53d |
Current reports
| Filed | Disclosed |
|---|---|
| Oct 29, 2026 | Results ↗ |
| Oct 20, 2026 | Director or officer change · Regulation FD ↗ |
| Oct 5, 2026 | Director or officer change · Regulation FD ↗ |
| Aug 6, 2026 | Results ↗ |
| Jul 16, 2026 | Regulation FD ↗ |
| May 15, 2026 | Shareholder vote ↗ |
| May 7, 2026 | Results ↗ |
| Apr 7, 2026 | Regulation FD · Other events ↗ |
| Mar 23, 2026 | Regulation FD · Other events ↗ |
| Feb 19, 2026 | Results · Director or officer change ↗ |
| Jan 9, 2026 | Regulation FD ↗ |
| Dec 17, 2025 | Regulation FD · Other events ↗ |